Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population. Read more about Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population.
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405. Read more about Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival. Read more about Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival.
Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer. Read more about Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer.
Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer. Read more about Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer.
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors. Read more about Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.
Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females. Read more about Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females.
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer. Read more about Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer. Read more about PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. Read more about Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
